Washington, DC - Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Washington, DC - The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Washington, DC - The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.

Washington, DC - President Donald J. Trump met with Congressman Elijah Cummings (D-MD) in the Oval Office to discuss rising prescription drug prices. This meeting was a result of a January telephone conversation, during which Congressman Cummings said that he and the President, “had more in common than differences.”

King’s Command Foods, LLC., a Kent, Wash. establishment, is recalling approximately 63,252 pounds of ground beef products that may be contaminated with extraneous materials, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Friday.

Washington, DC - The U.S. Food and Drug Administration approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.